Acadia Pharmaceuticals appoints Catherine Owen Adams CEO, shares fall

Acadia Pharmaceuticals

24/09/2024 16:51

** Shares of Acadia Pharmaceuticals  ACAD.O  fall 5.4% to
$15.42 
    ** California-based biopharmaceutical company appoints
Catherine Owen Adams as new CEO
        ** Previously, Adams was senior vice president and
general manager, U.S., at Bristol Myers Squibb
  
    ** Adams succeeds Steve Davis, company's CEO since Sept.
2015
    ** Thirteen of 19 brokerages rate stock "buy" or higher, 5
rate "hold" and one "sell"; their median PT is $26.5
    ** Including session's losses, stock down more than 50% YTD
    

 (Reporting by Sukriti Gupta)
 ((Sukriti.Gupta@thomsonreuters.com;))